Financial Information

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

Financial Information

Filing date Form Description Filing Group View
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
RW

Withdrawal of registration statement filed under the Securities Act

Other
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
SC 13G/A

An amendment to the SC 13G filing

Other
View HTML
S-1

Registration statement for face-amount certificate companies

Registration Statements
EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
EX-101.INS - XBRL INSTANCE DOCUMENT View HTML